Dermicon-BN Cream
Clotrimazole 1% + Beclomethasone Dipropionate 0.025% + Neomycin Sulphate 0.50%
Clinical Differentiators & Advantages
PCD Franchise Distribution
Verify if exclusive marketing and distribution rights for Dermicon-BN Cream are currently vacant in your target district.
Active Chemical Compounds & Molecular Architecture
Validated chemical entities, 2D skeletal bond diagrams, empirical molecular formulas, and receptor-level modes of action
Broad-spectrum antifungal decimating fungal ergosterol cell membranes.
Topical corticosteroid delivering rapid relief from erythema, swelling, and severe itching.
Aminoglycoside antibiotic preventing and eliminating bacterial superinfections.
Approved Clinical Indications & Disease Burden
Pharmacodynamic Mechanism of Action
Acts in Three Ways: Clotrimazole disrupts fungal cell membrane ergosterol biosynthesis, killing dermatophytes and yeasts. Beclomethasone suppresses inflammatory prostaglandins and cytokines, rapidly alleviating intense itching and erythema. Neomycin binds to bacterial 30S ribosomal subunits to eradicate secondary gram-positive and gram-negative invaders.
Dosage & Administration Protocol
Cleanse affected skin gently, then apply a thin layer 2 to 3 times daily.
Precautions, Warnings & Contraindications
B2B Commercial & Shipping Metrics
Moisture-sealed 5-ply export corrugation
Includes visual aids & promotional inputs
Private label & institutional supply
Standard pharmaceutical commercial tariff
Certificate of Analysis (COA), Stability Study Reports (Zone IVb), Finished Product Specs (FPS), and Material Safety Data Sheet (MSDS).